| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 7 | |
| #2 | Brazil | 3 | |
| #3 | Canada | 3 | |
| #4 | China | 3 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | Israel | 3 | |
| #7 | Republic of Korea | 3 | |
| #8 | Singapore | 3 | |
| #9 | United States | 3 | |
| #10 | WIPO (World Intellectual Property Organization) | 3 | |
| #11 | Philippines | 2 | |
| #12 | Hungary | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vitt Daniel | 27 |
| #2 | Kohlhof Hella | 26 |
| #3 | Gröppel Manfred | 14 |
| #4 | Tasler Stefan | 12 |
| #5 | Chevrier Carine | 12 |
| #6 | Mühler Andreas | 10 |
| #7 | Zaja Mirko | 9 |
| #8 | Felding Jakob | 9 |
| #9 | Groppel Manfred | 6 |
| #10 | Leban Johann | 5 |
| Publication | Filing date | Title |
|---|---|---|
| EP3765439A1 | Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
| KR20200090204A | Dosage regimen of bidofludimus for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases | |
| BR112020004332A2 | 1- (4-isoxazol-5-yl) -1h-pyrazol-1-yl) -2-methylpropan-2-ol derivatives and related compounds as inhibitors of il-17 and ifn-gamma for the treatment of autoimmune diseases and chronic inflammation |